Letter ·
NAMD Comments on Office of National Drug Control Policy’s (ONDCP) 2026 Strategy
On June 20, NAMD formally commented on the Office of National Drug Control Policy’s (ONDCP) 2026 National Drug Control Strategy.
Author
- NAMD Staff
Focus Areas
Program Stream
In June 2025, NAMD submitted comments to the Office of National Drug Control Policy (ONDCP) on the development of its 2026 National Drug Control Strategy. NAMD recommends to prioritize Medicaid’s role in addressing substance use disorder (SUD) by supporting the SUD and mental health workforce, enhancing cross-system collaboration, expanding access to treatment during reentry from incarceration, and streamlining federal processes for innovation.
Read NAMD’s full comments here.
Related resources
Turning the Tide: Q&A with West Virginia Medicaid Director Cindy Beane on Substance Use Treatment Progress
NAMD Comments on Draft Templates for Documenting Compliance with Mental Health Parity Requirements
CMS recently issued a set of templates and instructional guides to document compliance with mental health and substance...
Stay Informed
Drop us your email and we’ll keep you up-to-date on Medicaid issues.